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A gene encoding a novel secreted protein in mice, humans and zebrafish was 
identified, and named Neucrin.  Mouse Neucrin consists of 343 amino acids with a 
cysteine-rich domain in its carboxyl terminal region.  The positions of ten cysteine 
residues in the cysteine-rich domain are similar to those of Dickkopfs (Dkks), secreted 
Wnt antagonists.  However, whereas Dkks have two cysteine-rich domains, Neucrin has 
only one.  Neucrin as well as Dkks bound to LDL receptor-related protein 6 and inhibited 
the stabilization of cytosolic -catenin, indicating that Neucrin is an antagonist of 
canonical Wnt signaling.  Mouse Neucrin expression was not detected in any major tissues 
in the adult, but was detected in developing neural tissues, including the brain and spinal 
cord.  The expression pattern of Neucrin is distinct from that of any Dkk.  Neucrin is a 
unique secreted Wnt antagonist that is predominantly expressed in developing neural 
tissues.      
 
 




During the development of multicellular organisms, various signaling pathways are 
activated in a highly coordinated manner to ensure proper morphogenesis.  Secreted 
signaling molecules such as fibroblast growth factors (Fgfs), bone morphogenic proteins 
(Bmps), Wnts, and Hedgehogs (Hhs) play crucial roles in morphogenesis by influencing 
the intracellular signaling events of their neighbors from a distance.  Wnts comprise a 
large family of growth factors that are involved in diverse processes in development and 
disease [1,2].  Wnts are subjected to negative regulation by numerous secreted antagonists 
including the secreted frizzled-related protein (sFRP), Wnt inhibitory factor 1 (Wif1), 
Cerberus, Wise and the Dickkopf (Dkk) family [3].  The Dkk gene family comprises at 
least four members in vertebrates (Dkk1-Dkk4).  Dkks contain two conserved cysteine-rich 
domains. The cysteine-rich domains display a characteristic spacing of cysteine residues 
and other conserved amino acids.  Outside of the domains, Dkks show little sequence 
similarity [3-5].   
Many secreted signaling proteins and their regulators play crucial roles in cell 
proliferation and differentiation.  The identification and characterization of novel secreted 
signaling proteins are expected to provide new insights into the mechanism of cell 
proliferation and differentiation.   We identified a number of genes encoding novel 
secreted proteins from mouse cDNAs of unknown function in the DNA databases.   
Among these proteins, we reported Ectodin, Neudesin, and Brorin.  Ectodin plays crucial 
roles in tooth morphogenesis [6,7].  Neudesin and Brorin are potentially involved in neural 
development [8-10].  We also have identified a novel secreted protein, Neucrin, which has 
a cysteine-rich domain.  The positions of ten cysteine residues in this domain are similar 
to those of Dkks that are secreted Wnt antagonists.  We report here the identification of 
Neucrin, a novel secreted antagonist to canonical Wnt signaling, which is predominantly 
expressed in developing neural tissues.      
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Materials and methods 
 
Identification of mouse and human Neucrin.  Amino acid sequences predicted from mouse 
cDNAs of unknown function in nucleotide sequence databases were randomly analyzed 
using PSORT  (Prediction of Protein Sorting Signals and Localization Sites in Amino 
Acid Sequences).   Many cDNAs encoding putative secreted proteins were identified.  
Full-length cDNAs were isolated by polymerase chain reaction (PCR) with the embryonic 
cDNA as a template and cloned into a vector DNA, pGEM-T  (Promega).  We termed one 
of them mouse Neucrin.   
 Human NEUCRIN cDNAs was also identified in a homology-based search of human 
cDNA or genomic DNA sequences in nucleotide sequence databases with the amino acid 
sequence of mouse Neucrin. 
Forced Expression of mouse neucrin in CHO-S cells.  The mouse Neucrin cDNA with a 
DNA fragment encoding a Myc-tag (EQKLISEEDL) and a His6-tag at the 3’ terminus of 
the coding region was constructed in a vector DNA, pcDNA3.1(+) (Invitrogen).  CHO-S 
cells (2.3X10
5
 cells/ml) (Gibco) in a serum-free medium, CHO-S-SFM (Gibco), were 
plated on 24-well dishes (0.5 ml/well), cultured at 37˚C for 16 h, and then transfected with 
the Neucrin cDNA (0.8 mg) using Lipofectamine 2000 (Invitrogen) at 37˚C for 4 h.  After 
the transfection, CHO-S cells were further cultured in fresh CHO-S-SFM at 37 ˚C for 72 h.  
The cells were lysed and the protein with the Myc tag in the lysate or medium was 
detected by Western blotting with anti-Myc tag antibody (Cell Signaling) as described 
[11].  
Reverse transcription-polymerase chain reaction.  RNA was extracted from mouse tissues 
or mouse embryos using an RNeasy Mini Kit (QIAGEN).  cDNA was amplified from the 
RNA by reverse transcription-polymerase chain reaction (RT-PCR) using the following 
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primers (5’ primer / 3’ primer): mouse Neucrin, 5’-gacagggagagccaatggca-3’ / 5’-
caccaactagggcactagatgt-3’ (1058 bp fragment); mouse Gapdh [10].  
In situ hybridization.  Section in situ hybridization was preformed using mouse embryos 
as described [10].  An 
35
S-labeled mouse Neucrin sense or antisense RNA probe was 
transcribed from NotI or SphI-digested mouse Neucrin cDNA cloned in the pGEM-T 
using T7 or SP6 RNA polymerase with uridine 5’- -[35S]thiotriphosphate (~30 
TBq/mmol) (Amersham Biosciences), respectively. 
Neucrin binding assay.  mfz8CRD-IgG/pRK5 was described previously [12].  LRP6N-
IgG/pcDNA3.1(+) was generated by fusion of the extracellular domain of mouse LRP6 
with an IgG tag.  The Brorin-IgG/pcDNA3.1(+) construct contains the full-length Brorin 
[10]  fused with an IgG tag.  The human embryonic kidney cell line 293T was maintained 
in high-glucose Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal 
bovine serum (FBS) in 5% CO2 at 37˚C.  293T cells were transfected with the DNA using 
FuGene6 reagent (Roche) according to the manufacturer’s protocol.  Advanced DMEM:F-
12 (1:1) serum-free medium was used to obtain the conditioned medium (CM).  Neucrin, 
Brorin, fz8CRD and LRP6N proteins in CM were examined by Western blotting with 
anti-Myc antibody or anti-human IgG antibody  (1:4,000) (Jackson Immunoresearch).  
Brorin-IgG, fz8CRD-IgG, or LRP6N-IgG in CM was conjugated with Protein A 
Sepharose beads (GE Healthcare).  After one wash with PBS/0.3M NaCl and three washes 
with PBS, the beads were incubated with CM containing Neucrin-Myc at 4˚C overnight, 
washed with PBS/0.3M NaCl four times, and then boiled for 5 min in gel loading buffer.  
The elutes were examined by Western blotting. 
-catenin stabilization assay.  293T cells were grown in 35-mm wells in DMEM 
containing 10% FBS and were ~80% confluent at the time of the assay.  Cells were 
washed twice with serum-free DMEM and incubated at 37˚C with 1 ml of CM containing 
Neucrin-Myc.  After a 3-h incubation, the culture was supplemented with recombinant 
mouse Wnt-3a for a further 2h.  The cells were then washed with PBS, lysed in 50 l of 
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lysis buffer (0.1% Saponin, 25 mM HEPES, and 75 mM Potassium Acetate), and 
centrifuged at 15,000 rpm for 5 min at 4°C.  Protein concentrations were determined using 
the Bio-Rad protein assay reagent (Bio-Rad Laboratories).  Aliquots containing 5 g of 
protein were examined by Western blotting with anti- -catenin antibody (H-102; Santa 
Cruz).  Equal loading of the samples was confirmed by probing the blots with mouse anti-




Identification of mouse and human Neucrin  
We identified mouse embryonic cDNAs encoding novel putative secreted proteins by 
analyzing amino acid sequences predicted from mouse cDNAs of unknown function in the 
nucleotide sequence database with a computer program for the prediction of protein 
localization sites in cells (PSORT).  The full-length cDNAs were isolated by PCR with 
mouse embryonic cDNA as a template.  One of them encodes a putative secreted protein 
of 343 amino acids with a putative signal sequence (24 amino acids) at its amino-terminus 
(GenBank
TM
 accession code AB301918) (Fig. 1A).  We termed it Neucrin (neural tissue-
specific cysteine-rich protein), as it was predominantly expressed in mouse embryonic 
neural tissues as described below.  Neucrin has a cysteine-rich domain in its carboxyl 
terminal region (Fig. 1A).  Positions of ten cysteine residues in the cysteine-rich domain 
are similar to those in the second cysteine-rich domains of members of the Dkk family, 
although the amino acid sequence of the domain is less similar to that in Dkks (Fig. 1B).  
Outside of the cysteine-rich domain, Neucrin is unique with no primary structural 
similarity to any known proteins including Dkks. 
Human Neucrin cDNA (AB301919) was also identified in a homology-based search 
of human cDNA sequences in the nucleotide sequence databases with the amino acid 
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sequence of mouse Neucrin.  The amino acid sequence of human Neucrin (349 amino 
acids) is highly similar (~76% identity) to that of mouse Neucrin (Fig. 1A). 
 
Forced expression of mouse Neucrin in cultured cells 
To examine whether Neucrin is a secreted protein, mouse Neucrin cDNA was 
expressed in cultured cells.  CHO-S cells expressing mouse Neucrin protein with a Myc-
tag were created.  The Neucrin CHO-S cells were cultured for 72 h.  No bands were 
detected in either the lysate or culture medium of control CHO-S cells (Fig. 1C).  A major 
band of ~48 kDa was detected in the lysate of the Neucrin CHO-S cells.  The observed 
molecular mass was larger than the calculated molecular mass of the recombinant Neucrin 
protein (~38 kDa).  A major band of ~58 kDa with some minor bands of 52~31 kDas was 
also detected in the medium, indicating that Neucrin is a secreted protein (Fig. 1C).  The 
molecular mass in the medium was larger than the molecular mass in the cell lysate, 
indicating that Neucrin protein might be subjected to post-translational modification 
during the secretion process.  Neucrin has a potential glycosylation site at amino acid 
position 258 (N).  Neucrin also has several dibasic sites that might be subjected to 
proteolytic processing (Fig. 1A). 
 
Expression of Neucrin in mouse embryos and adult tissues 
Neucrin expression in mouse adult tissues (postnatal day 49, P49) was examined by 
RT-PCR (Fig. 2A).  Neucrin expression was not detected in any adult tissues examined.  
However, it was significantly detected in embryos at embryonic day 13.5 (E13.5).  The 
spatial expression pattern of Neucrin in mouse embryos at E13.5 and E18.5 was also 
examined by in situ hybridization.  The expression of Neucrin, shown by red grains, was 
predominantly detected in the developing neural tissues including the brain and spinal 
cord (Fig. 2C, E).  In contrast, essentially no grains were detected in these regions with the 
sense probe as a control (Fig. 2D, F).     
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As Neucrin expression was detected in mouse embryonic brain, its expression was 
also examined in the brain during embryonic and postnatal development (E13.5 ~ P49).  
Neucrin was abundantly expressed in the embryonic brain at all the stages examined (Fig. 
2B).  However, its expression in the postnatal brain significantly decreased with 
development (Fig. 2B).  These results indicate that Neucrin is preferentially expressed in 
the brain at embryonic and early postnatal stages.  
 
Binding of Neucrin to LRP6 receptor and Neucrin’s inhibition of -catenin’s stabilization 
Dkks are secreted proteins that negatively regulate the canonical Wnt signaling 
pathway, indicating that Neucrin might also have this function.  Dkk1 is a high-affinity 
ligand for LDL receptor-related protein (LRP) 6 and does not bind to the Frizzled (Fz) 
family receptors [13].  We examined whether Neucrin bound to the extracellular domain 
of LRP6 or Fz8.  A Myc-fused form of mouse Neucrin (Neucrin-Myc), an IgG-fused form 
of the cysteine-rich domain (CRD) of mouse Fz8 (Fz8CRD-IgG) or the extracellular 
domain of mouse LPR6 (LRP6N-IgG), and an IgG-fused form of Brorin, a Bmp 
antagonist, (Brorin-IgG) as a negative control were prepared from transiently transfected 
293T cells.  CMs were subjected to immunoprecipitation followed by Western blotting.  
Neucrin was co-immunoprecipitated with LRP6N-IgG but not with Fz8CRD-IgG or 
Brorin-IgG (Fig. 3A). 
Canonical Wnt signaling is mediated by the transcriptional effecter -catenin.  
Activation of the canonical Wnt signaling pathway results in the stabilization of cytosolic 
-catenin.  We examined whether the inhibition of -catenin’s stabilization by Neucrin 
occurred in the extracellular environment.  The steady-state level of -catenin protein in 
293T cells was examined.  Treatment of the cells with Neucrin CM inhibited the 
stabilization of cytosolic -catenin triggered by Wnt3a protein (Fig. 3B).  This result 






Wnts play crucial roles in diverse processes in development and disease [1,2].  Wnts 
are subjected to negative regulation by numerous secreted antagonists [3].  Dkks are 
secreted Wnt antagonists.  The Dkk gene family consists of at least four members in 
vertebrates (Dkk1-Dkk4).  Dkk genes encodes proteins of ~250-350 amino acids, which are 
subjected to posttranslational modifications including glycosylation and proteolytic 
processing.  Dkks contain two conserved cysteine-rich domains including the N-terminal 
(first) domain and C-terminal (second) domain. The cysteine-rich domains display a 
characteristic spacing of cysteine residues and other conserved amino acids.  Outside of 
the domains, Dkks show little sequence similarity [3].  The second domain alone is 
sufficient for Wnt antagonist activity [4,5].   
We identified Neucrin, a novel secreted protein, in mice and humans.  The amino acid 
sequences of the two proteins are significantly similar.  Neucrin has only one cysteine-rich 
domain in its carboxyl terminal region.  The positions of ten cysteine residues in the 
cysteine-rich domain are similar to those in the second cysteine-rich domains of members 
of the Dkk family, although the amino acid sequence of the domain is less similar to that 
of Dkks.  In addition, except for the positions of cysteine residues, Neucrin is unique with 
no primary structural similarity to any known proteins including Dkks.  These results 
indicate that the functional domain of Neucrin might be located in the carboxyl terminal 
region including the cysteine-rich domain.   
Dkk1 that has cysteine-rich domains in their carboxyl terminal region is an LRP6 
ligand and inhibits the canonical Wnt/ -catenin signalling by preventing the formation of 
the Fz-LRP6 complex induced by Wnt [4].  Neucrin that has a cysteine-rich domain in its 
carboxyl terminal region also bound to LRP6 but not Fz8.  Therefore, Neucrin is also an 
LRP6 ligand.  Furthermore, exogenously added Neucrin also inhibited Wnt3a’s stabilizing 
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effect on -catenin.  These results indicate that neucrin is a secreted Wnt antagonist and 
inhibits canonical Wnt/ -catenin signaling by binding to LRP6. 
Gene knockout studies suggest roles of Wnts in neural development in mice.  The 
brain’s development is greatly impaired in Wnt-1 knockout mice [14,15].   The 
development of the hippocampus is also impaired in Wnt-3a knockout mice [16].  
Furthermore, Wnt-1 and Wnt-3a double knockout mice have an additional reduction in the 
size of the rostral hindbrain [17].  These results indicate that Wnt signaling plays crucial 
roles in neural development. 
Dkk1 was originally identified as a gene conferring Spemann head organizer activity 
in Xenopus embryos [18].  Dkk1 is specifically expressed in the anterior mesendoderm, 
which has a potent head-inducing activity.  In zebrafish, dkk1 is also expressed in 
organizer derivatives of gastrulating embryos [19].  Overexpression of dkk1 in zebrafish 
embryos suppresses defects in the development of forebrain, eyes, and notochord in boz 
mutants, which have organizer deficiencies [20].  Dkk1 knockout mice lack head 
structures anterior to the mid-hindbrain boundary [21].  Although Dkk2 knockout mice are 
viable, they are blind [22].  These results also indicate that Wnt signaling plays crucial 
roles in neural development.   
Neucrin expression was not detected by RT-PCR in major adult tissues including the 
brain in mice.  In contrast, in mouse embryos, Neucrin is predominantly expressed in 
neural tissues including the brain and spinal cord.  The embryonic neural tissue-specific 
expression pattern of Neucrin is distinct from that of members of the Dkk family [3,23].  
These results indicate that neucrin potentially has roles in neural development.  
During our present study in progress, we have learned that Neucrin is identical with 
draxin, which is a secreted repulsive guidance protein for spinal cord and forebrain 
commissures and shares no homology with known guidance cues [24].  draxin deficient 
mice show defasciculation of spinal cord commissural axons and absence of forebrain 
commissures [24].    Recently, it also has been reported that Wnts function as axon 
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guidance molecules [25].  These findings suggest that Neucrin/draxin potentially functions 
as a repulsive guidance molecule by inhibiting Wnt signaling. 
In conclusion, Neucrin is a unique secreted Wnt antagonist identified in mice and 
human.  Neucrin is predominantly expressed in developing neural tissues.  The present 
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Fig. 1.  Comparison of amino acid sequences and forced expression of recombinant mouse 
Neucrin in cultured cells.  (A) Comparison of amino acid sequences of mouse Neucrin and 
human NEUCRIN. The numbers refer to amino acid positions.  Asterisks indicate 
identical amino acid residues in the sequences.  Underlined sequences indicate putative 
secreted signal sequences and cysteine-rich domains.  Dashes indicate gaps introduced to 
align sequences.  (B) Comparison of amino acid sequences of a cysteine-rich domain of 
mouse Neucrin and the second cysteine-rich domains of mouse Dkk1 and Dkk2.  The 
numbers refer to positions of cysteine residues indicated by open boxes.  (C) CHO-S cells 
were transfected with the empty vector (Control) and the mouse Neucrin-expression 
vector (Neucrin).  
 
Fig. 2.  The expression of Neucrin in mouse adult tissues, embryos, and embryonic and 
postnatal brains.  (A,B) Neucrin expression in adult tissues and embryos was examined by 
RT-PCR (A).  Neucrin expression in mouse brain at different developmental stages was 
examined by RT-PCR (B).  The expression of Gapdh was also examined as a control.  (C-
F) The localization of Neucrin mRNA in embryos.  Sagittal sections of mouse embryos at 
E13.5 (C,D) and E18.5 (E,F) were examined by in situ hybridization with an 
35
S-labeled 
antisense (C,E) or sense (D,F) mouse Neucrin RNA probe.  Red grains superimposed 




Fig. 3.  Binding of Neucrin to the extracellular domains of the LRP6 receptor and 
degradation of -catenin by Neucrin.  (A) Neucrin-Myc binding to Brorin-IgG, Fz8CRD-
IgG or LRP6N-IgG.  Neucrin-Myc CM was added after Brorin-IgG, Fz8CRD-IgG or 
LRP6N-IgG in CM was pre-bound to ProteinA-sepharose.  (B) 293T cells were pretreated 
for 3 h with either control or Neucrin CM, and then treated with Wnt3a protein for a 
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